Continuous release formulations

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 4942035
SERIAL NO

06716651

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Pharmaceutical compositions comprising a pharmacologically active polypeptide and a pharmacologically or veterinarily acceptable amphipathic, non-cross-linked linear, branched or graft block copolymer, which has a minimum weight average molecular weight of 5,000, in which the hydrophobic component is biodegradable and the hydrophilic component may or may not be biodegradable, the composition being capable of absorbing water to form a hydrogel when placed in an aqueous, physiological-type environment; copolymers suitable for use in said compositions; and method for the manufacture of such copolymers.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
IMPERIAL CHEMICAL INDUSTRIESPLC MILLBANK A CORP OF GREAT BRITAIN LONDON S W 1

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Churchill, Jeffrey R Northwich, GB 4 652
Hutchinson, Francis G Lymm, GB 12 1307

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation